30
Participants
Start Date
March 6, 2018
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
cyclophosphamide, fludarabine, and antithymocyte globulin
"1. Cyclophosphamide 50 mg/kg/day i.v. daily on days -3 and -2 (for 2 days)~2. Fludarabine 30 mg/m2/day i.v. daily on days -7to -2 (for 6 days)~3. Antithymocyte globulin (Thymoglobulin) 1.5 mg/kg/day (for HLA-matched sibling donor HCT) or 3.0 mg/kg/day (for other alternative donor HCT) i.v. daily on days -3 to -1 (for 3 days)"
Asan Medical Center, University of Ulsan College of Medicine, Seoul
Lead Sponsor
Asan Medical Center
OTHER